Daewon Pharmaceutical said Thursday that padoprazan (DW4421), its investigational treatment for gastroesophageal reflux ...

Curocell, a Korean cell therapy company, said it is seeking to expand the use of its CAR-T therapy Rimqarto (anbalcabtagene ...

GC Biopharma said Friday it received approval from the Ministry of Food and Drug Safety (MFDS) for Hunterase ICV (idursulfase ...

For Professor Chang Dong-gune, an orthopedic surgeon at Yeouido St. Mary's Hospital, treating spinal disease increasingly ...

Korea will expand health insurance coverage for five drugs for rare, hard-to-treat diseases next month, extending Crysvita ...

The number of counties in Korea without an obstetrician-gynecologist could nearly triple from nine in 2025 to 25 by 2035, ...

Samjin Pharmaceutical's Lorazepam Injection, an emergency medicine used to stop prolonged seizures, including potentially ...

The Supreme Court has overturned a lower court ruling upholding a pediatrician's license suspension for administering a ...

GC Biopharma and Hanmi Pharmaceutical said Friday they have signed an exclusive licensing agreement with BioMarin ...

Hanlim Pharmaceutical has signed a memorandum of understanding (MOU) with Japanese venture capital firm DCI Partners to ...

NEX-I plans to pursue global licensing deals for its immuno-oncology and antibody-drug conjugate (ADC) candidates following ...

Yuhan Corp. said Wednesday its third-quarter consolidated revenue rose about 6 percent from a year earlier to 604.3 billion ...